
Sign up to save your podcasts
Or


Click here to access the homepage of the episode!
Benefit-risk assessments are made by various stakeholders including sponsors, regulators, payers, physicians, and patients throughout the life-cycle of a treatment.
The understanding of data plays a vital role in weighting positive and negative effects of medications.
In this episode, we give you an introduction to what benefit-risk (BR) assessment is in order for you to understand your role.
By Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry4.4
99 ratings
Click here to access the homepage of the episode!
Benefit-risk assessments are made by various stakeholders including sponsors, regulators, payers, physicians, and patients throughout the life-cycle of a treatment.
The understanding of data plays a vital role in weighting positive and negative effects of medications.
In this episode, we give you an introduction to what benefit-risk (BR) assessment is in order for you to understand your role.

78,438 Listeners

32,021 Listeners

30,680 Listeners

43,548 Listeners

9,533 Listeners

497 Listeners

164 Listeners

344 Listeners

8,529 Listeners

6,090 Listeners

29,202 Listeners

18 Listeners

3,007 Listeners

18 Listeners

23 Listeners